Literature DB >> 6611118

Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography.

T N Chase, N L Foster, P Fedio, R Brooks, L Mansi, G Di Chiro.   

Abstract

Local cerebral glucose metabolism and psychometric function were compared in 17 patients with Alzheimer's disease and 5 healthy age-matched controls. Performance on tests of global intellectual function averaged 30 to 45% lower in the Alzheimer's group. Mean cortical glucose metabolism, as determined by positron emission tomography following fluorine-18-labeled fluorodeoxyglucose administration, was reduced by 30% in the Alzheimer's group. There was a significant positive correlation between the degree of overall dementia and the amount of metabolic reduction. The distribution of cortical hypometabolism was not uniform: the posterior parietal lobes and contiguous portions of the posterior temporal and anterior occipital lobes were most severely involved. The frontal cortex was relatively spared. These findings are compatible with the major clinical deficits found in patients with Alzheimer's disease and may help focus future biochemical probes into the pathophysiology of this disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611118     DOI: 10.1002/ana.410150732

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

1.  A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.

Authors:  M O Habert; U Spampinato; J L Mas; M L Piketty; M C Bourdel; J de Recondo; P Rondot; S Askienazy
Journal:  Eur J Nucl Med       Date:  1991

Review 2.  Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.

Authors:  M Isabel G Lopez Sanchez; Peter van Wijngaarden; Ian A Trounce
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

3.  Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Authors:  Jessica B S Langbaum; Kewei Chen; Richard J Caselli; Wendy Lee; Cole Reschke; Daniel Bandy; Gene E Alexander; Christine M Burns; Alfred W Kaszniak; Stephanie A Reeder; Jason J Corneveaux; April N Allen; Jeremy Pruzin; Matthew J Huentelman; Adam S Fleisher; Eric M Reiman
Journal:  Arch Neurol       Date:  2010-04

4.  Ideomotor apraxia in patients with dementia of Alzheimer type.

Authors:  S Della Sala; F Lucchelli; H Spinnler
Journal:  J Neurol       Date:  1987-02       Impact factor: 4.849

5.  Phosphofructokinase activity in fibroblasts from patients with Alzheimer's disease and age- and sex-matched controls.

Authors:  N R Sims; J P Blass
Journal:  Metab Brain Dis       Date:  1986-03       Impact factor: 3.584

6.  Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.

Authors:  S Yamaguchi; K Meguro; M Itoh; C Hayasaka; M Shimada; H Yamazaki; A Yamadori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

7.  An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease.

Authors:  E Masliah; M Mallory; L Hansen; M Alford; R DeTeresa; R Terry
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia.

Authors:  K Meguro; C Doi; M Ueda; T Yamaguchi; H Matsui; S Kinomura; M Itoh; K Yamada; H Sasaki
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

9.  Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.

Authors:  Hillary D Protas; Kewei Chen; Jessica B S Langbaum; Adam S Fleisher; Gene E Alexander; Wendy Lee; Daniel Bandy; Mony J de Leon; Lisa Mosconi; Shannon Buckley; Diana Truran-Sacrey; Norbert Schuff; Michael W Weiner; Richard J Caselli; Eric M Reiman
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

10.  Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Jessica B S Langbaum; Kewei Chen; Wendy Lee; Cole Reschke; Dan Bandy; Adam S Fleisher; Gene E Alexander; Norman L Foster; Michael W Weiner; Robert A Koeppe; William J Jagust; Eric M Reiman
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.